These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Identification of Kaempferol as Viral Entry Inhibitor and DL-Arginine as Viral Replication Inhibitor from Selected Plants of Indian Traditional Medicine against COVID-19: An Jayaprakashkamath A; Murali M; Nair B; Benny F; Mani RP; Suresh D; Presanna AT; Areekkara AN; Nath LR Curr Comput Aided Drug Des; 2023; 19(4):313-323. PubMed ID: 36635906 [TBL] [Abstract][Full Text] [Related]
10. Expression of MMP2, MMP9, MT1-MMP, TIMP1, and TIMP2 mRNA in valvular lesions of the heart. Soini Y; Satta J; Määttä M; Autio-Harmainen H J Pathol; 2001 Jun; 194(2):225-31. PubMed ID: 11400152 [TBL] [Abstract][Full Text] [Related]
12. MMP2 and MMP9 participate in S1P-induced invasion of follicular ML-1 thyroid cancer cells. Kalhori V; Törnquist K Mol Cell Endocrinol; 2015 Mar; 404():113-22. PubMed ID: 25643979 [TBL] [Abstract][Full Text] [Related]
13. Rat pancreatic stellate cells secrete matrix metalloproteinases: implications for extracellular matrix turnover. Phillips PA; McCarroll JA; Park S; Wu MJ; Pirola R; Korsten M; Wilson JS; Apte MV Gut; 2003 Feb; 52(2):275-82. PubMed ID: 12524413 [TBL] [Abstract][Full Text] [Related]
14. Relationship between matrix metalloproteinase 2 and lung cancer progression. Guo CB; Wang S; Deng C; Zhang DL; Wang FL; Jin XQ Mol Diagn Ther; 2007; 11(3):183-92. PubMed ID: 17570740 [TBL] [Abstract][Full Text] [Related]
15. Integrated Multi-Omics Investigations of Metalloproteinases in Colon Cancer: Focus on MMP2 and MMP9. Buttacavoli M; Di Cara G; Roz E; Pucci-Minafra I; Feo S; Cancemi P Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830271 [TBL] [Abstract][Full Text] [Related]
16. In vivo migration of transplanted myoblasts requires matrix metalloproteinase activity. El Fahime E; Torrente Y; Caron NJ; Bresolin MD; Tremblay JP Exp Cell Res; 2000 Aug; 258(2):279-87. PubMed ID: 10896779 [TBL] [Abstract][Full Text] [Related]
17. Isorhamnetin Downregulates MMP2 and MMP9 to Inhibit Development of Rheumatoid Arthritis through SRC/ERK/CREB Pathway. Liu XR; Li SF; Mei WY; Liu XD; Zhou RB Chin J Integr Med; 2024 Apr; 30(4):299-310. PubMed ID: 38212502 [TBL] [Abstract][Full Text] [Related]
18. Intracerebroventricular administration of an endothelin ET(B)-receptor agonist increases expression of matrix metalloproteinase-2 and -9 in rat brain. Koyama Y; Tanaka K J Pharmacol Sci; 2010; 114(4):433-43. PubMed ID: 21127388 [TBL] [Abstract][Full Text] [Related]